Edwards Lifesciences share price logo

Edwards Lifesciences

NYSE: EW

Large Cap

$85.15

-0.04

(-0.05%)

as on

Edwards Lifesciences Stock Performance

as on October 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $84.89
    $86.48
    downward going graph

    0.31%

    Downside

    1.56%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $72.30
    $96.29
    downward going graph

    15.09%

    Downside

    13.08%

    Upside

    downward going graph

Edwards Lifesciences share price movements today

Previous Close
$85.19
Open
$85.29
Volume
1.4M
Market Cap
$49.1B
Day's Low - High
$84.89 - $86.48
52 Week Low - High
$72.30 - $96.29

Edwards Lifesciences Historical Returns

1 Month Return
-5.16 %
3 Month Return
-9.77 %
1 Year Return
+ 10.48 %
3 Year Return
+ 22.34 %
5 Year Return
-24.16 %

Edwards Lifesciences Stock Fundamentals & Key Indicators

Check Edwards Lifesciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$49.1B

EPS (TTM)

1.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.25%

PE Ratio (TTM)

49.05

Industry PE ratio

24.51

PEG Ratio

-0.65

EBITDA

1.5B

Revenue (TTM)

6.5B

Profit Margin

77.98%

Return On Equity TTM

9.69%

Edwards Lifesciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Edwards Lifesciences image
Edwards Lifesciences
Buy$49.1B-24.16%49.0577.98%0.00%
Medtronic image
Medtronic
Buy$110.4B-32.15%21.1666.69%3.31%
Stryker image
Stryker
StrongBuy$105.6B2.69%28.1065.17%1.29%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$171.0B-16.82%31.3056.80%2.56%
Boston Scientific image
Boston Scientific
StrongBuy$62.7B-2.74%17.4671.16%0.00%

Stock Returns calculator for Edwards Lifesciences Stock including INR - Dollar returns

The Edwards Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edwards Lifesciences investment value today

Current value as on today

₹1,19,903

Returns

₹19,903

(+19.9%)

Returns from Edwards Lifesciences Stock

₹10,484 (+10.48%)

Dollar Impact

₹9,419 (+9.42%)

Analyst Recommendation on Edwards Lifesciences Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Edwards Lifesciences. Average target price of $100.96

Edwards Lifesciences Share Price Target

Get share price movements and forecasts by analysts on Edwards Lifesciences.

What analysts predicted

15.66%UPSIDE

Target Price

$100.96

Current Price

$85.15

Analyzed by

10 Analysts

High

$105

Target

$100.96

Low

$85

Edwards Lifesciences target price $100.96, a slight upside of 15.66% compared to current price of $85.15. According to 10 analysts rating.

Indian Investors' Interest in Edwards Lifesciences Stock

Search interest for Edwards Lifesciences Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:43% versus previous 30 day period

Edwards Lifesciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1,329
1,385
1,354
1,385
1,412
1,532
1,553
1,569
1,648
1,741
Gross Profit
1,040
1,088
1,091
1,093
1,111
1,189
1,209
1,229
1,289
1,350
Operating Income
355
364
350
312
394
430
425
370
514
519
EBITDA
409
426
428
483
470
400
387
133
499
519
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
38
39
34
42
36
38
39
42
40
-
Income Before Tax
371
386
402
390
433
400
348
90
459
519
Income Tax Expense
46
20
40
45
70
64
56
26
78
278
Net Income
351
363
3,070
385
358
329
291
91
380
241
Net Profit Margin
78.25%
78.51%
80.59%
78.91%
78.65%
77.64%
77.88%
78.30%
78.21%
77.56%

Edwards Lifesciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3,435
3,722
4,348
4,386
5,232
5,382
5,010
5,439
6,067
Gross Profit
2,552
2,800
3,192
3,287
4,006
4,215
3,972
4,322
4,740
Operating Income
1,010
1,092
1,197
1,296
1,610
1,702
1,427
1,378
1,636
EBITDA
1,140
872
1,308
1,074
1,890
1,960
1,534
1,723
1,429
Interest Expense
23
33
27
22
24
26
17
19
-
Depreciation
81
77
114
135
163
166
144
155
156
Income Before Tax
1,034
761
1,166
916
1,702
1,767
1,372
1,548
1,272
Income Tax Expense
451
39
119
93
198
245
152
152
216
Net Income
622
722
1,046
823
1,503
1,521
1,402
4,174
1,073
Net Profit Margin
74.30%
75.23%
73.43%
74.94%
76.57%
78.31%
79.30%
79.46%
78.13%

Edwards Lifesciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
351
365
3,069
385
356
331
290
91
380
241
Operating Cash Flow
-53
371
351
-127
280
290
573
450
43
651
Investing Cash Flow
63
124
2,701
-576
85
-172
-427
-198
-92
-193
Financing Cash Flow
61
-96
-976
28
-258
52
-740
-11
-451
0
Change in Cash
81
429
2,035
-624
90
141
-595
244
-492
462

Edwards Lifesciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
583
722
1,046
823
1,503
1,521
1,402
4,169
1,069
Operating Cash Flow
1,000
926
1,179
1,054
1,732
1,218
895
542
1,595
Investing Cash Flow
-647
76
-595
-531
-1,722
252
173
2,312
-712
Financing Cash Flow
-473
-1,101
-115
-486
-356
-1,584
-711
-983
-956
Change in Cash
-111
-104
465
15
-332
-94
375
1,910
-119

Global Institutional Holdings in Edwards Lifesciences

Check out the Institutions with significant holdings in Edwards Lifesciences.

Funds
Holdings
Vanguard
10.76%
VANGUARD INDEX FUNDS
9.75%
iShares
6.14%
SPDR
4.00%
VANGUARD SPECIALIZED FUNDS
2.56%
See all

Edwards Lifesciences News & Key Events

  • img

    Today's Timeline - 01 October

    Fri, 02:00 AM

    -

    Edwards Lifesciences receives FDA approval for AUTUS Size-Adjustable Valve for pediatric patients requiring pulmonary valve replacement.

Insights on Edwards Lifesciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Edwards Lifesciences Corp has shown a consistent growth in revenue over the last 8 quarters. The revenue has increased from $1.35 billion to $1.74 billion, with an average quarterly growth rate of 3.5%. This upward trend indicates a positive performance for the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EW has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, EW has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, EW stock has moved up by 5.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Edwards Lifesciences Corp has seen a decline in its net profit over the last two quarters. The profit dropped from $380.70 million to $241.89 million, reflecting an average decrease of 36.5% per quarter.

About Edwards Lifesciences

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
OrganisationEdwards Lifesciences
HeadquartersOne Edwards Way, Irvine, CA, 92614, US
IndustryMedical - Devices
CEOBernard J. Zovighian

Key Management of Edwards Lifesciences

Name

Title

Mr. Donald E. Bobo Jr.

Corporate Vice President of Strategy & Corporate Development

Mr. Daveen Chopra

Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies

Dr. Todd Brinton FACC, M.D.

Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer

Mr. Snehashish Sarkar

Senior VP and Chief Information & Digital Officer

Mr. Bernard J. Zovighian

CEO & Director

Ms. Annette Maria Bruls

Corporate Vice President of EMEA, Canada, & Latin America

Ms. Theodora Mistras

Corporate VP & CFO

Mr. Joseph Nuzzolese

Corporate Vice President of Global Operations & Quality

Mr. Andrew M. Dahl

Principal Accounting Officer, Senior VP & Corporate Controller

Mr. Mark D. Peterson

Corporate VP & General Counsel

FAQs

What is Edwards Lifesciences share price today?

Edwards Lifesciences share price today is $85.15 as on at the close of the market. Edwards Lifesciences share today touched a day high of $86.48 and a low of $84.89.

What is the 52 week high and 52 week low for Edwards Lifesciences share?

Edwards Lifesciences share touched a 52 week high of $96.29 on and a 52 week low of $72.30 on . Edwards Lifesciences stock price today i.e. is closed at $85.15,which is 11.57% down from its 52 week high and 17.77% up from its 52 week low.

What is Edwards Lifesciences's market capitalisation today?

Edwards Lifesciences market capitalisation is $0.05T as on .

How to invest in Edwards Lifesciences Stock (EW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edwards Lifesciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Edwards Lifesciences Stock (EW) from India?

Indian investors can start investing in Edwards Lifesciences (EW) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Edwards Lifesciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Edwards Lifesciences share’s latest price of $85.15 as on October 3, 2026 at 8:46 am IST, you will get 0.1174 shares of Edwards Lifesciences. Learn more about fractional shares .

What are the returns that Edwards Lifesciences has given to Indian investors in the last 5 years?

Edwards Lifesciences stock has given -24.16% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?